[1. Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. The Lancet. 2013 Jun;381(9881):1943-55. DOI: 10.1016/S0140-6736(12)62187-410.1016/S0140-6736(12)62187-4]Open DOISearch in Google Scholar
[2. Bartram CR, Schrauder A, Köhler R, Schrappe M. Acute lymphoblastic leukemia in children: treatment planning via minimal residual disease assessment. Dtsch Arzteblatt Int. 2012 Oct;109(40):652-8.10.3238/arztebl.2012.0652]Search in Google Scholar
[3. Harrison CJ. Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia. Br J Haematol. 2009 Jan;144(2):147-56. DOI: 10.1111/j.1365-2141.2008.07417.x10.1111/j.1365-2141.2008.07417.x]Open DOISearch in Google Scholar
[4. Pui C-H, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet Lond Engl. 2008 Mar 22;371(9617):1030-43. DOI: 10.1016/S0140-6736(08)60457-210.1016/S0140-6736(08)60457-2]Open DOISearch in Google Scholar
[5. Mullighan CG, Collins-Underwood JR, Phillips LAA, Loudin MG, Liu W, Zhang J, et al. Rearrangement of CRLF2 in B-progenitor and Down syndrome associated acute lymphoblastic leukemia. Nat Genet. 2009 Nov;41(11):1243-6. DOI: 10.1038/ng.46910.1038/ng.469278381019838194]Open DOISearch in Google Scholar
[6. Kamariah Ibrahim, Siti Sarah Daud, Yeow-Liang Seah, Allen E. Yeoh, Hany Ariffin. Rapid Detection of Prognostically Important Childhood Acute Lymphoblastic Leukemia Chimeric Transcripts Using Multiplex SYBR Green Real-Time Reverse Transcription PCR. Ann Clin Lab Sci. 2008;38(4):338-43.]Search in Google Scholar
[7. Harrison CJ. Acute lymphoblastic leukemia. Clin Lab Med. 2011 Dec;31(4):631-647, ix. DOI: 10.1016/j.cll.2011.08.01610.1016/j.cll.2011.08.01622118741]Open DOISearch in Google Scholar
[8. Brüggemann M, Schrauder A, Raff T, Pfeifer H, Dworzak M, Ottmann OG, et al. Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. Leukemia. 2010 Mar;24(3):521-35. DOI: 10.1038/leu.2009.26810.1038/leu.2009.26820033054]Search in Google Scholar
[9. Ivanov IC, Jitaru D, Grigore GE, Zlei M, Ivanov A, Dumitraș S, et al. Infant acute leukemia with lineage switch at relapse expressing a novel t(4;11)(q21;q23) MLL-AF4 fusion transcript. Rev Romana Med Lab. 2013;21(1):47-58. DOI:10.2478/rrlm-2013-0017 DOI: 10.2478/rrlm-2013-001710.2478/rrlm-2013-0017DOI:10.2478/rrlm-2013-0017]Open DOISearch in Google Scholar
[10. Boldeanu FM, Gruia AT, Ordodi VL, Serban M, Bader P, Kreyenberg H. Childhood Acute Lymphoblastic Leukemia: Detection of Minimal Residual Disease after Allogeneic Transplantation. Rev Romana Med Lab. 2012;20(3):245-53]Search in Google Scholar
[11. Jardan D, Talmaci R, Jardan C, Coriu D, Colita A, Colita A, et al. Real-time qPCR for assessment of minimal residual disease in acute myeloid and lymphoid leukemia. Rev Romana Med Lab. 2011;19(4):349-57]Search in Google Scholar
[12. van der Does-van den Berg A, Bartram CR, Basso G, Benoit YC, Biondi A, Debatin KM, et al. Minimal requirements for the diagnosis, classification, and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the “BFM Family” Cooperative Group. Med Pediatr Oncol. 1992;20(6):497-505. DOI: 10.1002/mpo.295020060310.1002/mpo.29502006031435520]Open DOISearch in Google Scholar
[13. Gabert J, Beillard E, van der Velden VHJ, Bi W, Grimwade D, Pallisgaard N, et al. Standardization and quality control studies of “real-time” quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Against Cancer Program. Leukemia. 2003 Dec;17(12):2318-57. DOI: 10.1038/sj.leu.240313510.1038/sj.leu.240313514562125]Open DOISearch in Google Scholar
[14. R Core Team. R: A Language and Environment for Statistical Computing [Internet]. R Foundation for Statistical Computing; 2014. Available from: http://www.R-project.org]Search in Google Scholar
[15. Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol Off J Am Soc Clin Oncol. 2012 May 10;30(14):1663-9. DOI: 10.1200/JCO.2011.37.801810.1200/JCO.2011.37.8018]Open DOISearch in Google Scholar
[16. Bassan R, Hoelzer D. Modern therapy of acute lymphoblastic leukemia. J Clin Oncol Off J Am Soc Clin Oncol. 2011 Feb 10;29(5):532-43. DOI: 10.1200/JCO.2010.30.138210.1200/JCO.2010.30.1382]Open DOISearch in Google Scholar
[17. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012 Feb;62(1):10-29. DOI: 10.3322/caac.2013810.3322/caac.20138]Open DOISearch in Google Scholar
[18. Roganovic J. Acute Lymphoblastic Leukemia in Children. In: Guenova M, editor. Leukemia [Internet]. In- Tech; 2013 [cited 2017 Apr 19]. Available from: http://www.intechopen.com/books/leukemia/acute-lymphoblastic-leukemia-in-children10.5772/55655]Search in Google Scholar
[19. Lustosa de Sousa DW, de Almeida Ferreira FV, Cavalcante Félix FH, de Oliveira Lopes MV. Acute lymphoblastic leukemia in children and adolescents: prognostic factors and analysis of survival. Rev Bras Hematol E Hemoter. 2015 Jul; 37(4):223-9. DOI: 10.1016/j.bjhh.2015.03.00910.1016/j.bjhh.2015.03.009]Open DOISearch in Google Scholar
[20. Pui C-H, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009 Jun 25; 360(26):2730-41. DOI: 10.1056/NEJMoa090038610.1056/NEJMoa0900386]Open DOISearch in Google Scholar
[21. Gökbuget N, Kneba M, Raff T, Trautmann H, Bartram C-R, Arnold R, et al. Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies. Blood. 2012 Aug 30;120(9):1868-76.DOI: 10.1182/blood-2011-09-37771310.1182/blood-2011-09-377713]Open DOISearch in Google Scholar
[22. Liang D-C, Shih L-Y, Yang C-P, Hung I-J, Liu H-C, Jaing T-H, et al. Frequencies of ETV6-RUNX1 fusion and hyperdiploidy in pediatric acute lymphoblastic leukemia are lower in far east than west. Pediatr Blood Cancer. 2010 Sep;55(3):430-3. DOI: 10.1002/pbc.2262810.1002/pbc.22628]Open DOISearch in Google Scholar
[23. Weltgesundheitsorganisation, Swerdlow SH, International Agency for Research on Cancer, editors. WHO classification of tumours of haematopoietic and lymphoid tissues: [... reflects the views of a working group that convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), Lyon, October 25 - 27, 2007]. 4. ed. Lyon: Internat. Agency for Research on Cancer; 2008. 439 p. (World Health Organization classification of tumours).]Search in Google Scholar
[24. Maurer J, Janssen JW, Thiel E, van Denderen J, Ludwig WD, Aydemir U, et al. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet Lond Engl.1991 May 4;337(8749):1055-8. DOI: 10.1016/0140-6736(91)91706-Z10.1016/0140-6736(91)91706-Z]Search in Google Scholar
[25. Sazawal S, Bhatia K, Gutierrez MI, Saxena R, Arya LS, Bhargava M. Paucity of TEL-AML 1 translocation, by multiplex RT-PCR, in B-lineage acute lymphoblastic leukemia (ALL) in Indian patients. Am J Hematol. 2004 May;76(1):80-2. DOI: 10.1002/ajh.2000010.1002/ajh.2000015114604]Open DOISearch in Google Scholar
[26. Oyekunle A, Haferlach T, Kröger N, Klyuchnikov E, Zander AR, Schnittger S, et al. Molecular Diagnostics, Targeted Therapy, and the Indication for Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia. Adv Hematol. 2011;2011:1-8. DOI: 10.1155/2011/15474510.1155/2011/154745321628622110503]Open DOISearch in Google Scholar
[27. Diakos C, Xiao Y, Zheng S, Kager L, Dworzak M, Wiemels JL. Direct and indirect targets of the E2APBX1 leukemia-specific fusion protein. PloS One. 2014;9(2):e87602. DOI: 10.1371/journal.pone.008760210.1371/journal.pone.0087602391365524503810]Search in Google Scholar
[28. Hu Y, He H, Lu J, Wang Y, Xiao P, Li J, et al. E2APBX1 exhibited a promising prognosis in pediatric acute lymphoblastic leukemia treated with the CCLGALL2008 protocol. OncoTargets Ther. 2016 Nov;Volume 9:7219-25. DOI: 10.2147/OTT.S11525710.2147/OTT.S115257512580127920559]Open DOISearch in Google Scholar
[29. Vey N, Thomas X, Picard C, Kovascovicz T, Charin C, Cayuela JM, et al. Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/ E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study. Leukemia. 2006 Dec;20(12):2155-61. DOI: 10.1038/sj.leu.240442010.1038/sj.leu.240442017039234]Open DOISearch in Google Scholar
[30. Ballerini P, Landman-Parker J, Cayuela JM, Asnafi V, Labopin M, Gandemer V, et al. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE- 93: the effect of TLX3/HOX11L2 gene expression on outcome. Haematologica. 2008 Nov;93(11):1658-65. DOI: 10.3324/haematol.1329110.3324/haematol.1329118835836]Open DOISearch in Google Scholar
[31. Mansur MB, Emerenciano M, Brewer L, Sant’Ana M, Mendonça N, Thuler LCS, et al. SIL-TAL1 fusion gene negative impact in T-cell acute lymphoblastic leukemia outcome. Leuk Lymphoma. 2009 Aug;50(8):1318-25. DOI: 10.1080/1042819090304001410.1080/1042819090304001419562638]Search in Google Scholar
[32. D’Angio M, Valsecchi MG, Testi AM, Conter V, Nunes V, Parasole R, et al. Clinical features and outcome of SIL/TAL1-positive T-cell acute lymphoblastic leukemia in children and adolescents: a 10-year experience of the AIEOP group. Haematologica. 2015 Jan 1;100(1):e10-3.DOI: 10.3324/haematol.2014.11215110.3324/haematol.2014.112151428132725304610]Search in Google Scholar
[33. Matutes E, Pickl WF, van’t Veer M, Morilla R, Swansbury J, Strobl H et al. Mixed- phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011;117:3163-71 DOI: 10.1182/ blood-2010-10-31468210.1182/blood-2010-10-31468221228332]Open DOISearch in Google Scholar